DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: La...
FDA Drug Recall #D-1255-2016 — Class III — June 28, 2016
Recall Summary
| Recall Number | D-1255-2016 |
| Classification | Class III — Low risk |
| Date Initiated | June 28, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Golden State Medical Supply Inc. |
| Location | Camarillo, CA |
| Product Type | Drugs |
| Quantity | 2077 bottles |
Product Description
DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Esteve, SA, Martorelles, Barcelona --- NDC 60429-166-10
Reason for Recall
Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018
Distribution Pattern
Nationwide. No foreign distribution.
Lot / Code Information
Lot# GS011709, GS012352
Other Recalls from Golden State Medical Supply Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0235-2026 | Class II | Baclofen Tablets USP, 10 mg, 1000-count bottles... | Nov 26, 2025 |
| D-0158-2026 | Class II | NIACIN Extended-Release Tablets, USP, 1,000 mg,... | Oct 20, 2025 |
| D-0287-2025 | Class II | PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx ... | Mar 5, 2025 |
| D-0568-2024 | Class II | Duloxetine Delayed-Release Capsules, USP, 30mg,... | May 13, 2024 |
| D-0349-2024 | Class II | Fluticasone Propionate Nasal Spray USP, 50 mcg ... | Feb 14, 2024 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.